U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 17

1.
Full record GDS4456

High-risk bladder cancer

Analysis of bladder cancer specimens from a high-risk population of patients who underwent radical cystectomy (Memorial Sloan-Kettering Cancer Center cohort). Results provide insight into the prediction of survival in high-risk urothelial carcinoma of the urinary bladder.
Organism:
Homo sapiens
Type:
Expression profiling by array, transformed count, 2 disease state, 5 specimen sets
Platform:
GPL570
Series:
GSE31684
93 Samples
Download data: CEL
2.

DNA copy number gain at 1q23.3 is associated with poor survival in metastatic bladder cancer

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Genome variation profiling by SNP array; Genome variation profiling by genome tiling array
Platforms:
GPL10150 GPL15793
128 Samples
Download data: CEL, TXT
Series
Accession:
GSE39282
ID:
200039282
3.

DNA copy number gain at 1q23.3 is associated with poor survival in metastatic bladder cancer [Agilent]

(Submitter supplied) Metastatic urothelial carcinoma (UC) of the bladder is associated with multiple somatic copy number alterations (SCNAs). We evaluated SCNAs to identify predictors of poor survival in patients with metastatic UC treated with platinum chemotherapy.
Organism:
Homo sapiens
Type:
Genome variation profiling by genome tiling array
Platform:
GPL10150
94 Samples
Download data: BED, PDF, TXT
Series
Accession:
GSE39281
ID:
200039281
4.

DNA copy number gain at 1q23.3 is associated with poor survival in metastatic bladder cancer [Affymetrix]

(Submitter supplied) Metastatic urothelial carcinoma (UC) of the bladder is associated with multiple somatic copy number alterations (SCNAs). We evaluated SCNAs to identify predictors of poor survival in patients with metastatic UC treated with platinum chemotherapy.
Organism:
Homo sapiens
Type:
Genome variation profiling by SNP array
Platform:
GPL15793
34 Samples
Download data: BED, CEL, PDF, TXT
Series
Accession:
GSE39280
ID:
200039280
5.

Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer  

(Submitter supplied) Urothelial carcinoma of the bladder is characterized by significant variability in clinical outcomes depending on stage and grade. The addition of molecular information may improve our understanding of such heterogeneity and enhance prognostic prediction. The purpose of this study was to validate and improve published prognostic signatures for high-risk bladder cancer.
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS4456
Platform:
GPL570
93 Samples
Download data: CEL, TXT
Series
Accession:
GSE31684
ID:
200031684
6.

Discovery and validation of a novel expression signature for recurrence in high-risk bladder cancer post-cystectomy

(Submitter supplied) Purpose: Selecting muscle-invasive bladder cancer patients for adjuvant therapy is currently based on clinical variables with limited power. We hypothesized that genomic-based signatures can outperform clinical models to identify patients at higher risk. Method:Transcriptome-wide expression profiles were generated using 1.4 million feature-arrays on archival tumors from 225 patients who underwent radical cystectomy and had muscle-invasive and/or node-positive bladder cancer. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL5188
199 Samples
Download data: CEL
Series
Accession:
GSE57933
ID:
200057933
7.

Identification of nine genomic regions of amplification in bladder cancer, correlation with stage, and potential prognositic and therapeutic value

(Submitter supplied) We sought to test the hypothesis that ascertainment of genome-wide copy number alterations in bladder cancer may have value for clinical management. We performed a genome wide analysis of 164 bladder cancer samples and 27 bladder cancer cell lines to identify genetic changes associated with disease characteristics. Multiplex inversion probe (MIP) analysis, a newly developed genomic technique, was used to study 80 bladder cancers to identify mutations and copy number changes. more...
Organism:
Homo sapiens
Type:
Genome variation profiling by SNP array
Platform:
GPL13270
80 Samples
Download data: CEL
Series
Accession:
GSE44323
ID:
200044323
8.

Predictive Gene Signatures as Strong Prognostic Indicators of the Effectiveness of BCG Immunotherapy

(Submitter supplied) Full title: Predictive Gene Signatures as Strong Prognostic Indicators of the Effectiveness of Bacillus Calmette–Guérin (BCG) Immunotherapy in Primary pT1 Bladder Cancers Intravesical BCG immunotherapy is effective in prevention of recurrence and progression in many cases of non-muscle invasive bladder cancer, but many patients fail to respond. This study identified predictive gene signatures in primary pT1 bladder cancer with BCG immunotherapy. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6102
48 Samples
Download data: TXT, XLS
Series
Accession:
GSE19423
ID:
200019423
9.

Predective Value of Prognosis-Related Gene Expression Study in Primary Bladder Cancer

(Submitter supplied) This study aimed to identify the genetic signatures associated with disease prognosis in bladder cancer. We used 165 primary bladder cancer samples, 23 recurrent non-muscle invasive tumor tissues, 58 normal looking bladder mucosae surrounding cancer and 10 normal bladder mucosae for microarray analysis. Hierarchical clustering was used to stratify the prognosis-related gene classifiers. For validation, real-time reverse-transcriptase polymerase chain reaction (RT-PCR) of top-ranked 14 genes was performed. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6102
256 Samples
Download data: TXT, XLS
Series
Accession:
GSE13507
ID:
200013507
10.

Gene expression signatures predict outcome in non-muscle invasive bladder carcinoma - a multi-center validation study

(Submitter supplied) Background Clinically useful molecular markers predicting the clinical course of patients diagnosed with non-muscle invasive bladder cancer are needed to improve treatment outcome. Methods We used custom designed oligonucleotide microarrays to validate four previously reported gene expression signatures for molecular diagnosis of disease stage and carcinoma in situ, and for predicting disease recurrence and progression. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL4060
808 Samples
Download data: TXT
Series
Accession:
GSE5479
ID:
200005479
11.

Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer

(Submitter supplied) Background: Bladder-sparing trimodality therapy (TMT) is an alternative to radical cystectomy (RC) for muscle-invasive bladder cancer (MIBC), and biomarkers to inform therapy selection are needed. Objective: To evaluate immune and stromal signatures in MIBC treated with TMT.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL22995
136 Samples
Download data: CEL
Series
Accession:
GSE128701
ID:
200128701
12.

Micrometastasis primary tumors

(Submitter supplied) Primary tumors from a series of breast cancer patients evaluated for the presence of tumor cells in bone marrow. Samples were taken at primary surgery, RNA isolated from fresh frozen tumors, amplified and hybridized to 42k cDNA arrays. Set of arrays organized by shared biological context, such as organism, tumors types, processes, etc.
Organism:
Homo sapiens
Type:
Expression profiling by array
6 related Platforms
123 Samples
Download data
Series
Accession:
GSE3985
ID:
200003985
13.

MVAC treated tumors

(Submitter supplied) validation of the survival outcomes from MVAC-Avastin treated tumors
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL14951
49 Samples
Download data: TXT
Series
Accession:
GSE70691
ID:
200070691
14.

a phase 2 trial of DDMVAC and bevacizumab in urothelial cancer

(Submitter supplied) A prognostic gene expression signature in chemotherapy-naïve bladder cancer is predictive of clinical outcomes from neoadjuvant chemotherapy
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL14951
61 Samples
Download data: TXT
Series
Accession:
GSE69795
ID:
200069795
15.

Molecular Biomarker Signature for Bladder Cancer Detection

(Submitter supplied) In this study we applied differential gene expression analysis to exfoliated human urothelia obtained from patients of known bladder disease status. Selected targets from the microarray data were validated in an independent set of samples using a quantitative PCR approach.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
92 Samples
Download data: CEL, CHP
Series
Accession:
GSE31189
ID:
200031189
16.

Carboxypeptidase of glutamate-like gene as a tumor suppressor in pancreatic cancer cells and a prognostic marker for resected pancreatic cancer patients

(Submitter supplied) Pancreatic cancer is the fourth leading cancer-related death in United States. The clinical relevance of genomic imbalances in pancreatic cancer is uncertain. We performed array-comparative genomic hybridization (aCGH) in 44 resected pancreatic cancer specimens from a Korean cohort. We observed recurrent copy number gains were observed in chromosome 1q, 11q, 18q11.1-11.2, and 20q13.13; and losses in chromosome 2p, 9p, 10q, 14q, 15q, 18q12.2-23, 19q, 20q11.1, 21p, and 22q. more...
Organism:
Homo sapiens
Type:
Genome variation profiling by array
Platform:
GPL4093
44 Samples
Download data: TXT
Series
Accession:
GSE28732
ID:
200028732
17.

Molecular subtype classification of urothelial carcinoma in Lynch syndrome

(Submitter supplied) We aimed to provide a molecular description of Lynch syndrome-associated urothelial cancer in relation to molecular subtypes of sporadic bladder cancer. Whole genome mRNA expression profiles of 41 tumors and immunohistochemical stainings against FGFR3, KRT5, CCNB1, RB1, and CDKN2A (p16) of 37 tumors from Lynch syndrome patients were generated. Pathological data, microsatellite instability, anatomic location, and overall survival data was analyzed and compared with data from sporadic bladder cancer.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6244
41 Samples
Download data: CEL
Series
Accession:
GSE104922
ID:
200104922
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=2|qty=2|blobid=MCID_672de3005614fa636741a2ba|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center